Registration and Treatment of Pain During Eye Examination of Prematurity
NCT ID: NCT01552993
Last Updated: 2016-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
5 participants
INTERVENTIONAL
2012-03-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Paracetamol in Reducing Pain During Ophthalmological Examination for Retinopathy of Prematurity: a Prospective Randomised Trial
NCT01872871
Pain Management During Screening for Retinopathy of Prematurity
NCT04767178
The Preterm Infants' Paracetamol Study
NCT01938261
Effect of Prematurity on Renal Function in 5 Years Old Children
NCT00817921
Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants
NCT07112430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a double blinded, controlled and randomized study where the infants are examined and assessed either with or without the use of paracetamol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
paracetamol
Paracetamol mixture 20 mg/kg + pacifier and sucrose
paracetamol
Paracetamol mixture 20 mg/kg + pacifier and glucose
placebo
pacifier and sucrose only
sucrose
pacifier and sucrose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
paracetamol
Paracetamol mixture 20 mg/kg + pacifier and glucose
sucrose
pacifier and sucrose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
31 Weeks
37 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian University of Science and Technology
OTHER
St. Olavs Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hakon Bergseng, PhD
Role: PRINCIPAL_INVESTIGATOR
St. Olavs University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St.Olavs University Hospital
Trondheim, Trøndelag, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HB2012-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.